Establishment Labs Holdings Inc
(FRA:3E0)
€
43.2
0 (0%)
Market Cap: 1.20 Bil
Enterprise Value: 1.34 Bil
PE Ratio: 0
PB Ratio: 41.09
GF Score: 78/100 Establishment Labs Holdings Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 12, 2021 / 03:00PM GMT
Release Date Price:
€68
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Okay. I hear the chime. So that means it's time for the medtech portion of the conference. Welcome to day 2.5 of our in-person conference here in Laguna, and I hope you're having a good time. I know I am.
So this morning, in our first session, we have management from Establishment Labs. To my left here is Juan Jose Chacon, who's the President, CEO and Founder of the company; and then directly to his left is Raj Denhoy, who's joined as Head of Strategy and IR, who many of you, I'm sure, know.
So this will be a fireside chat. I have a lot of questions to ask. (Operator Instructions)
So guys, thanks a lot for joining us and looking forward to the conversation.
Juan Jose Chacon Quiros
Establishment Labs Holdings Inc. - Founder, CEO & Executive Director
Good morning, and thank you.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot